| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/15/2006 | CN1747937A Pyrimidine derivatives for the prevention of HIV infection |
| 03/15/2006 | CN1747936A Substituted azole derivatives as therapeutic agents |
| 03/15/2006 | CN1747934A Crystalline forms of pitavastatin calcium |
| 03/15/2006 | CN1747933A New mono-acylated o-phenylendiamines derivatives |
| 03/15/2006 | CN1747930A Compounds having prolyl oligopeptidase inhibitory activity |
| 03/15/2006 | CN1747926A Substituted amides |
| 03/15/2006 | CN1747921A Depigmentation agents |
| 03/15/2006 | CN1747744A Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
| 03/15/2006 | CN1747743A Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases |
| 03/15/2006 | CN1747741A Treatment of inflammatory bowel disease |
| 03/15/2006 | CN1747738A Sustained release of antifectives |
| 03/15/2006 | CN1747737A Carbohydrate conjugates to prevent abuse of controlled substances |
| 03/15/2006 | CN1747736A Compositon comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis |
| 03/15/2006 | CN1747735A Use of s-10 hydroxy-10, 11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders |
| 03/15/2006 | CN1747734A Use of dipyridamole or mopidamole for treatment and prevention of mmp-9-dependent disorders |
| 03/15/2006 | CN1747733A Treatment of bacterial diseases of the respiratory organs by locally applying fluoroquinolones |
| 03/15/2006 | CN1747732A 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists |
| 03/15/2006 | CN1747731A Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders |
| 03/15/2006 | CN1747730A Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity |
| 03/15/2006 | CN1747729A Methods for selectively inhibiting janus tyrosine kinase 3 (jak3) |
| 03/15/2006 | CN1747728A Compositions and methods for improving the condition of patients suffering from copd and other diseases |
| 03/15/2006 | CN1747727A Inhibitor for perioperative blood sugar elevation |
| 03/15/2006 | CN1747726A A therapeutic composition for the treatment of hiv-1 and hiv-2 |
| 03/15/2006 | CN1747725A Compositions and methods for treating upper respiratory congestion. |
| 03/15/2006 | CN1747724A Transdermal granisetron |
| 03/15/2006 | CN1747721A Composition for chemoembolotherapy of solid tumors |
| 03/15/2006 | CN1747719A Topical compositions and methods for treating pain |
| 03/15/2006 | CN1747718A Compositions comprising a defined polysaccharide component. |
| 03/15/2006 | CN1747717A Compositions comprising a polysaccharide component and one or more coating layers. |
| 03/15/2006 | CN1747716A Compositions comprising a plurality of particles or agglomerates having a defined particle size |
| 03/15/2006 | CN1747711A Melanogenesis inhibitor and skin preparation containing the same |
| 03/15/2006 | CN1747710A Increasing skin cell renewal with water-soluble vitamin e |
| 03/15/2006 | CN1746172A Preparation of plurichari |
| 03/15/2006 | CN1746171A Heterocyclic hepyramine derivative, its preparation and use thereof |
| 03/15/2006 | CN1746164A Protein antagonist with water channel |
| 03/15/2006 | CN1745846A Dental ulcerative glue |
| 03/15/2006 | CN1745830A Preparation of Zijing paste for eye vision recovery |
| 03/15/2006 | CN1745825A Salve for treating burn and scald |
| 03/15/2006 | CN1745803A Longxuejie extract with alpha-glycosidase inhibiting activity and its quality control |
| 03/15/2006 | CN1745791A Use of medicinal composition |
| 03/15/2006 | CN1745789A Head invigorating capsule and its preparation thereof |
| 03/15/2006 | CN1745786A Zhimiling preparation and its making method thereof |
| 03/15/2006 | CN1745763A Kunjing preparation and its making method thereof |
| 03/15/2006 | CN1745756A Use for treating AIDS from ginseng saponin |
| 03/15/2006 | CN1745755A Nucleotide analog composition and synthesis method |
| 03/15/2006 | CN1745754A Airphosphosodium clathrate compound and its preparation |
| 03/15/2006 | CN1745753A Nanometer Arrphosphosodium and preparation thereof |
| 03/15/2006 | CN1745752A Medicinal compound preparation for treating benign prostatic hyperplasia |
| 03/15/2006 | CN1745751A Preparation composition for eyes |
| 03/15/2006 | CN1745750A Lansoprazole liposome and its preparation |
| 03/15/2006 | CN1745749A Likejun capsule and production thereof |
| 03/15/2006 | CN1745748A Method for stabilizing mixed powders of potassium clavic acid in mixing, packing and transporting procedures |
| 03/15/2006 | CN1745747A Use of proanthocyanidin in preparing medicine for treating colitis |
| 03/15/2006 | CN1745746A Hydroxypropyl-beta-cyclodextrin coating material of borneol an dits preparing method |
| 03/15/2006 | CN1245419C Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses |
| 03/15/2006 | CN1245408C Use of Maituolaicin |
| 03/15/2006 | CN1245407C Composition of garcinolic acid compounds, its preparing process and medical composition using it as active component |
| 03/15/2006 | CN1245405C Piperazine derivatives |
| 03/15/2006 | CN1245404C Mercaptoacetylamide derivatives, process for their preparation and use thereof |
| 03/15/2006 | CN1245402C Indole derivatives, their preparation, medicinal compositions containing them and use thereof |
| 03/15/2006 | CN1245400C N-substituted benzothiophenesulfonamide derivatives |
| 03/15/2006 | CN1245398C Extraction technology of baicalein, medicinal composition and preparation technology of medicine |
| 03/15/2006 | CN1245394C Substituted phenylacetamides and their use as glucokinase activators |
| 03/15/2006 | CN1245391C Pyrimidine, Triazine and pyrazine derivatives as glutamate receptors |
| 03/15/2006 | CN1245390C Compound of multiple substituted uracil class, preparation method and usage |
| 03/15/2006 | CN1245389C Novel crystal of arylethenesulfonamide derivative and process for producing the same |
| 03/15/2006 | CN1245387C Use of 5-oxy-aporphine alkaloids in making hepatitis virus inhibiting activity drug |
| 03/15/2006 | CN1245385C Indole and dihydroindole derivatives |
| 03/15/2006 | CN1245382C 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 03/15/2006 | CN1245381C Phenylglycine derivatives |
| 03/15/2006 | CN1245376C Substituted 2-dialkylamino alkylbiphenyl derivatives |
| 03/15/2006 | CN1245209C External used Chinese medicine for pain stopping |
| 03/15/2006 | CN1245187C Medicine for treating eye disease caused by visceral disease |
| 03/15/2006 | CN1245186C Chinese traditional medicine for treating acute and chronic pharyngitis and its preparation method |
| 03/15/2006 | CN1245183C Traditional Chinese medicinal plaster for treating angiitis |
| 03/15/2006 | CN1245179C Hematinic agent of blood tonic |
| 03/15/2006 | CN1245176C Externally applied medicine for treating skin ulcer |
| 03/15/2006 | CN1245174C Oral quick disintegration tablet medicine for treating oral ulcer and its preparation method |
| 03/15/2006 | CN1245170C Health care composition for preventing and treating cadiac vascular diseases and its use |
| 03/15/2006 | CN1245169C Memory and perception improving pure natural composite preparation and its preparing process |
| 03/15/2006 | CN1245168C Storax and baras camphor oral disintegration tablet and its preparing process |
| 03/15/2006 | CN1245165C Preparation method and uses of hyaluronic acid gel with iron ion and medicine used for preventing adhesion after operation |
| 03/15/2006 | CN1245164C Cell growth regulating factor oral liquid and its preparation process |
| 03/15/2006 | CN1245163C Puerarin dispersing tablet composition and its preparation method |
| 03/15/2006 | CN1245162C Synergistic precursor medicine compound for treating Alzheimer disease |
| 03/15/2006 | CN1245161C A method of modulating ion channel functional activity |
| 03/15/2006 | CN1245160C Compound pressure-reduction preparation containing indapamide and angiotensin converzyme inhibitor |
| 03/15/2006 | CN1245159C Use of hydroxy saflor yellow pigment A in preparing medicine for treating and preventing cardiovascular and cerebrovascular diseases |
| 03/15/2006 | CN1245158C 片剂组合物 Tablet composition |
| 03/15/2006 | CN1245157C Novel fatty derivative for treatment of diabetes |
| 03/15/2006 | CN1245155C Oral pharmaceutical pulsed release dosage form |
| 03/15/2006 | CN1245154C Mouth cavity fast disintegrating tablet of Chinese medicine or natural medical matters and its preparing method |
| 03/15/2006 | CN1245153C Vitamin A liposome and its preparation method |
| 03/14/2006 | WO2007053135A1 Methods for diagnosis and treatment of cancer |
| 03/14/2006 | US7012158 Providing an intermediate compound having fluorine and a nitrile groups; selectively reducing nitrile group to form an amine group, further hydrolyzing the intermediate compound produced |
| 03/14/2006 | US7012146 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders |
| 03/14/2006 | US7012145 Method |
| 03/14/2006 | US7012143 Map kinases inhibitors; antiinflammatory agents; osteoporosis; antiarthritic agents; anticancer agents; antiischemic agents; cardiovascular disorders; autoimmune diseases |
| 03/14/2006 | US7012139 Wetting with a solution comprising a dialdehyde, adding an aqueous salt solution, drying and comminuting; for preparing a protective colloid, uses no acid catalysts, not changing viscosity |
| 03/14/2006 | US7012138 Chiral polysaccharide esters, one of the methods for preparing them and their uses for obtaining optically enriched acids or for chiral chromatography |